Senior Commercial Product Manager, NGS Segments
Danaher Corporation
Summary
The Senior Commercial Product Manager, NGS Segments is responsible for driving commercial strategy and sustainable growth across the NGS portfolio, with a particular focus on the Clinical, Pharma, and Biopharma customer segments. This role combines customer insights, competitive intelligence, market opportunity analysis, and portfolio strategy to identify growth opportunities and guide commercialization priorities.
Job description
Working with key stakeholders including Sales, R&D, Applications Development, and Marketing, the Senior Commercial Product Manager will translate technical capabilities and market intelligence into differentiated positioning, customer-focused messaging, and integrated go-to-market strategies to increase adoption, strengthen competitive differentiation, and deliver revenue and margin growth. This position is part of the NGS Business Unit in Boulder, CO, and can be remote or on-site.
In this role, you will have the opportunity to:
- Develop and execute NGS commercial strategies and annual growth plans to drive revenue, market penetration, customer adoption, and portfolio performance.
- Identify and prioritize growth opportunities across key customer segments by understanding workflows, unmet needs, purchasing criteria, scientific applications, and business challenges.
- Use voice-of-customer insights, competitive intelligence, market trends, and sales data to shape portfolio strategy and commercialization priorities.
- Lead cross-functional teams to solve complex commercial challenges, develop segmentation and targeting strategies, and identify innovative growth opportunities.
- Develop sales tools, training, customer-facing content, and commercial programs, while effectively communicating recommendations and influencing stakeholders to support execution.
The essential requirements of the job include:
- Bachelor's degree with 5+ years of experience in biological sciences (biology, chemistry, biochemistry)
- 3+ years of experience in Next Generation Sequencing product management, strategic marketing, commercial experience, or other relevant technical environment
- Willingness and ability to travel approximately 20% domestically and internationally
- Demonstrated experience working with Pharma and Biopharma customers, including an understanding of relevant research, translational, biomarker, clinical development, or drug development workflows.
- Demonstrated success developing portfolio strategies, commercial growth plans, product positioning, and go-to-market programs.
It would be a plus if you also possess:
- PhD in biological sciences (biology, chemistry, biochemistry) or a related field
- Demonstrated understanding of competitors, technologies, trends, and key challenges in NGS, Pharma, Clinical, and Oncology research markets.
- 5+ years in the biotechnology, genomics, next-generation sequencing (NGS) industry, or other relevant technical environment
Requirements
- Bachelor's degree in biological sciences (biology, chemistry, biochemistry)
- 5+ years of experience in biological sciences
- 3+ years of experience in Next Generation Sequencing product management, strategic marketing, commercial experience, or other relevant technical environment
- Willingness and ability to travel approximately 20% domestically and internationally
- Demonstrated experience working with Pharma and Biopharma customers
- Understanding of research, translational, biomarker, clinical development, or drug development workflows
- Demonstrated success developing portfolio strategies, commercial growth plans, product positioning, and go-to-market programs
Benefits
- Health care program
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.